Updated August 11, 2026 · AltIndex alt-data view going into the print
AltIndex AI Score on Ligand Pharmaceuticals is 50 — signals are mixed heading into the print. Underlying trend: 2 of 5 tracked signals trending up over the last 3 months.
Ligand Pharmaceuticals (LGND) is trading at $288.75, up 30.5% over the last 3 months (from $221.21 three months ago).
Trends across the last 3 months — the run-up to Ligand Pharmaceuticals’s next earnings print.
| Signal | Current | 3-month change |
|---|---|---|
| Job postings | 0 | No 3-month baseline |
| LinkedIn headcount | 135 | ↑ +3.8% |
| Sentiment | 79% Bullish | → flat |
| Web traffic | 7,835 | ↑ +7.4% |
| Employee business outlook | 56% Neutral | → flat |
| X followers | 10,352 | → -0.2% |
Full daily-resolution trend charts on every signal are on the LGND ticker page.
AltIndex stock alerts fire when alt-data on LGND breaks out — web traffic spike, hiring surge, sentiment shift — often days before the earnings number confirms it.
Sign up to AltIndex →Other companies in the AltIndex universe reporting earnings in the next 2 weeks, sorted by AI Score.
Sign up to see the full daily-resolution trend charts on every signal AltIndex tracks for Ligand Pharmaceuticals — web traffic, hiring, 8-platform social audience, sentiment, insider trades and the full AI Score breakdown.
Sign up to AltIndex → Log in